The right choice depends on deficiency cause, route preference, tolerability, availability, and monitoring needs
This vial combines Ipamorelin (5mg) with CJC-1295 no DAC (5mg) for researchers studying their synergistic effect on GH pulses
Novo Nordisk says the US FDA has approved a once daily pill version of Wegovy, described as the first approved pill of its kind The company said trials showed average weight loss of 16.6%, with about a third of roughly 1,300 participants losing 20% or more Novo Nordisk expects a US launch in early January 2026, with investors pushing shares up sharply after the announcement amid strong competition in the weight loss market US regulators have approved an oral version of Wegovy for chronic weight management, giving Novo Nordisk the first daily pill in this drug class cleared for obesity treatment, according to the company and US media reports
You can cancel anytime through the patient portal in two clicks
It changed my life
Depending on the brand, dose, and local prescribing guidance, semaglutide may also be prescribed for long-term weight management in adults with obesity or overweight with weight-related health conditions